NO147562C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater

Info

Publication number
NO147562C
NO147562C NO783471A NO783471A NO147562C NO 147562 C NO147562 C NO 147562C NO 783471 A NO783471 A NO 783471A NO 783471 A NO783471 A NO 783471A NO 147562 C NO147562 C NO 147562C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
xantine
derivatives
Prior art date
Application number
NO783471A
Other languages
English (en)
Norwegian (no)
Other versions
NO147562B (no
NO783471L (no
Inventor
Sten Haakan Axel Ma Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO783471L publication Critical patent/NO783471L/no
Publication of NO147562B publication Critical patent/NO147562B/no
Publication of NO147562C publication Critical patent/NO147562C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO783471A 1977-10-14 1978-10-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater NO147562C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (3)

Publication Number Publication Date
NO783471L NO783471L (no) 1979-04-18
NO147562B NO147562B (no) 1983-01-24
NO147562C true NO147562C (no) 1983-05-18

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783471A NO147562C (no) 1977-10-14 1978-10-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater

Country Status (21)

Country Link
US (1) US4233303A (it)
EP (1) EP0001735B1 (it)
JP (1) JPS5479296A (it)
AT (1) AT363491B (it)
AU (1) AU521585B2 (it)
CA (1) CA1109470A (it)
CS (1) CS208756B2 (it)
DD (1) DD139855A5 (it)
DE (1) DE2862017D1 (it)
DK (1) DK148260C (it)
FI (1) FI66383C (it)
HK (1) HK6385A (it)
HU (1) HU180219B (it)
IE (1) IE47884B1 (it)
IT (1) IT1109208B (it)
NO (1) NO147562C (it)
NZ (1) NZ188566A (it)
SE (1) SE416810C (it)
SG (1) SG85584G (it)
SU (1) SU755199A3 (it)
ZA (1) ZA785335B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247655T1 (de) * 1994-12-13 2003-09-15 Euro Celtique Sa Dreifachsubstituierte thioxanthine
EP0814809B1 (en) * 1994-12-13 2003-08-13 Euroceltique S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
AU2004233852A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
WO2005105083A1 (en) * 2004-04-16 2005-11-10 Novacardia, Inc. Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
US4233303A (en) 1980-11-11
ZA785335B (en) 1979-09-26
IT1109208B (it) 1985-12-16
CS208756B2 (en) 1981-09-15
NZ188566A (en) 1984-07-06
IT7851499A0 (it) 1978-10-13
SE7711581L (sv) 1979-04-15
DE2862017D1 (en) 1982-10-28
SU755199A3 (en) 1980-08-07
IE47884B1 (en) 1984-07-11
DK453778A (da) 1979-04-15
FI66383B (fi) 1984-06-29
FI783126A (fi) 1979-04-15
SG85584G (en) 1985-06-07
ATA714478A (de) 1980-09-15
SE416810B (sv) 1981-02-09
AT363491B (de) 1981-08-10
IE782041L (en) 1979-04-14
EP0001735A1 (en) 1979-05-02
CA1109470A (en) 1981-09-22
DK148260C (da) 1986-02-10
SE416810C (sv) 1982-07-19
AU4036578A (en) 1980-04-17
HK6385A (en) 1985-02-01
DK148260B (da) 1985-05-20
EP0001735B1 (en) 1982-09-01
JPS5479296A (en) 1979-06-25
NO147562B (no) 1983-01-24
NO783471L (no) 1979-04-18
AU521585B2 (en) 1982-04-22
DD139855A5 (de) 1980-01-23
FI66383C (fi) 1984-10-10
HU180219B (en) 1983-02-28

Similar Documents

Publication Publication Date Title
NO147562C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
NO148813C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater
SE7800726L (sv) Forfarande for framstellning av renat albumin
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO152651C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
NO781630L (no) Fremgangsmaate ved fremstilling av svovelholdige benzimidazolderivater
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
SE7805676L (sv) Nytt forfarande for framstellning av alkaloider av leurosintypen
NO153260C (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme 9-hydroksyetoksyguaninderivater
NO145955C (no) Analogifremgangsmaate for fremstilling av oleandomycin-derivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner